Lucia Auerbach
Lucia Auerbach tracks how emerging health and wellness research filters into everyday habits, work performance, and consumer behavior. She writes trending news for Inc., with a focus on alcohol, health, wellness, and retail, turning dense studies into clear takeaways for an audience of entrepreneurs and decision-makers. Her coverage stands out for its emphasis on large-scale, peer-reviewed research and for highlighting counterintuitive findings that challenge conventional health advice.
Brain health, aging, and cognitive performance
Auerbach devotes much of her reporting to the aging brain and cognitive decline, repeatedly returning to new studies on memory, dementia risk, and neuroplasticity. She covers research on how a widely used vaccine is associated with reduced rates of cognitive decline among older adults, explaining how data from hundreds of thousands of Medicare beneficiaries reshapes thinking about prevention. She reports on work showing that brain health can improve well into a person’s 80s, drawing out what long-running studies of thousands of adults say about lifestyle, resilience, and later-life cognition.
Her pieces dig into specific mechanisms behind memory loss rather than staying at the level of general advice. She has written about a copper-based drug that boosted memory scores by more than 40 percent in early research, situating the drug in the broader search for long-term brain health treatments. In another article, she examines a Northwestern Medicine study that points to an overlooked space between brain cells—the extracellular matrix—as a key to understanding why post-menopausal women face higher Alzheimer’s risk, linking hormone changes, neural architecture, and memory function in plain language. She also covers placebo effects, such as a study where a “fake” memory pill still improved cognitive performance, using those findings to explore expectations, motivation, and the psychology of self-improvement.
Lifestyle habits, longevity, and workplace wellbeing
Beyond the lab, Auerbach focuses on how everyday choices about sleep, food, and movement accumulate into long-term health and productivity outcomes. She reports on research showing that irregular bedtimes double the risk of serious cardiovascular events and cut productivity by about 30 percent, making a direct connection between heart health and day-to-day work performance. She covers studies on ultra-processed foods, explaining how something as ordinary as a daily bag of chips can shorten attention span and raise dementia risk, and why food engineered for pleasure can undermine focus and long-term brain health.
Her longevity coverage often challenges popular supplements and routines. In a piece on a review of more than 150,000 people, she explains why vitamin D and calcium, long marketed as essentials for strong bones and fracture prevention, offer little meaningful protection against falls or broken bones in older adults, forcing readers to rethink assumptions about aging and prevention. Another article on gut health walks through research showing how microscopic particles in the digestive tract, luminal exosomes, may accelerate aging throughout the body and fuel chronic inflammation, tying together metabolism, immune function, and sleep quality.
Auerbach also reports on the human cost of modern work. She covers data showing that mentions of burnout in job reviews jumped 65 percent year over year, and explores how younger workers in particular are rejecting hustle culture in favor of sustainability and boundaries. Her reporting on back pain looks at how a brief, five-minute movement habit during desk work can substantially reduce one of the top reasons for employee absences, translating clinical findings from sports medicine into pragmatic workplace routines.
Alcohol, consumer behavior, and retail trends
Alcohol and retail behavior form another strand of Auerbach’s beat, where she often links health trends to shifts in spending and industry strategy. She has reported on a Deloitte study showing why some consumers, including high earners, are cutting their alcohol spending by half, spelling out how changing attitudes toward wellness, weight-loss drugs, and moderation ripple through bars and beverage companies. Her coverage includes stories on legacy beer brands pausing long-running campaigns and rethinking their positioning as younger drinkers shift preferences.
In these pieces, she writes about alcohol not only as a product category but as a barometer of generational values and health priorities. She connects shifts in drinking habits to broader cultural conversations about aging, stress management, and the search for healthier social routines. The same analytical style she brings to medical research—careful attention to data and study design—shows up in her treatment of consumer surveys and market analyses, making her alcohol and retail coverage unusually grounded for a trending news beat.
Generational health and the human side of business
Auerbach frequently frames health stories through a generational lens, asking what new findings mean for Gen Z and Millennials in particular. She covers research indicating that younger generations are aging faster than their parents, exploring how stress, diet, technology use, and work conditions might be accelerating biological wear and tear. She also reports on neuroscience that upends standard narratives about risky behavior, highlighting studies that link lower dopamine levels—not higher—to greater risk-taking, and considering how that reframes assumptions about youth, addiction, and impulsive decision-making.
Her business-facing work extends to profiles and personal narratives where health and ambition intersect. In a feature on entrepreneur Codie Sanchez, she chronicles how someone who built a multimillion-dollar enterprise on relentless effort was forced by a major personal event to step back, using the story to examine overwork, identity, and long-term sustainability. Across these stories, Auerbach treats founders, workers, and consumers as part of the same health ecosystem, showing how individual choices, corporate cultures, and scientific discoveries feed into one another.
Before her current news role, Auerbach gained experience as a writer and editor in media and the art world, including co-authoring coverage of design and fashion. That background gives her a comfort with culture and aesthetics that complements her data-heavy reporting. Taken together, her work offers a consistent through-line: rigorous, study-driven health and wellness stories that explain not just what the latest research found, but how it changes the way people live, work, and buy.
4 more health journalists.
Abida Tasnim
Abida Tasnim is a health writer for The Daily Star who focuses on clear, practical guidance that helps readers recognise risks early and act before everyday illnesses turn into wider public health problems. She reports on infectious disease prevention, using measles coverage to show how outbreaks start with individual decisions and behaviours, not just hospital statistics. Her work explains what happens during an outbreak and then anchors the story in simple steps people can take, such as avoiding crowded places when symptoms appear, practising good hygiene, and seeking medical advice early. She writes direct, action‑oriented health explainers that turn clinical questions about contagion and disease burden into everyday choices. Across her beat, she stresses early recognition, timely care, and prevention as the foundations of healthier communities.
Adrián Carballo Casla
Adrián Carballo Casla stands out for turning complex cohort data on ageing into clear, food‑level advice on what older adults should eat to protect brain health and slow chronic disease. He is a researcher in nutritional epidemiology focused on ageing and chronic disease prevention and a postdoctoral researcher in geriatric epidemiology at Karolinska Institutet, writing health explainers for The Conversation. He reports on how diet quality, especially Mediterranean and Mind‑style patterns, shapes dementia risk, grey matter loss and neurocognitive ageing, and how healthy versus pro‑inflammatory diets alter multimorbidity trajectories. His articles translate findings on flavonoids, polyphenols, folate, omega‑3 fats and dietary nitrates into specific food choices and small, practical changes. Much of his coverage is anchored in his own studies on multimorbidity, high‑risk older adults and tailored dietary recommendations, often syndicated to other outlets.
Ahmed Elbediwy
Ahmed Elbediwy brings a lab-based understanding of cancer biology and clinical biochemistry to public-facing health reporting, linking drug mechanisms and molecular pathways to everyday choices about medicines and products. He writes for The Conversation on weight-loss injections, cancer overdiagnosis and anti-ageing supplements, focusing on obesity medicine, cancer signalling, screening trade-offs, skincare and supplement science. His pieces on GLP-1 drugs such as Ozempic, Wegovy and Mounjaro explain why some people do not respond, how gut hormones and appetite signals work, and where psychological support and nutrition fit alongside prescriptions. He co-authors explainers on cancer risk and overdiagnosis and on whether supplements can reverse ageing, separating established knowledge from emerging research. An award-winning senior lecturer at Kingston University, he favours clear, structured explainers, careful definition of key terms and evidence-based appraisal over hype.
Amanda Sheppeard
Amanda Sheppeard is a managing editor and health journalist known for long, detailed explainers that connect complex clinical research, disability policy and political narratives with the daily realities of doctors and patients. She works at The Medical Republic across editorial leadership and commercial content while reporting widely on medicine for its specialist titles. Her real beat spans autism, disability policy, autoimmune disease, infectious threats and system pressures in primary care and hospitals. She covers subjects such as autism diagnosis and the NDIS, rheumatology’s clinical shifts, weight-loss agents in rheumatoid arthritis, infection control, antimicrobial resistance and new modalities like CAR T-cell therapy and microneedles. She reports by doing the synthesis inside the story, linking trial design, molecular targets, funding rules and policy changes to concrete decisions and workflows in clinics and hospitals.